Emblem (EMC) Stock Price, News & Analysis

Company Overview

Emblem Corp. produces, distributes, and sells medical cannabis and cannabis derivatives in Canada. The company also operates medical cannabis education centers to provide education services for making informed decisions about medical cannabis treatment options to physicians and patients. In addition, it provides various accessories. Emblem Corp. has a strategic partnership with GreenSpace Brands to develop and commercialize cannabidiol infused health and beauty products. The company is headquartered in Toronto, Canada.

Key Stats

• Today's Range: $1.84 to $1.88
• 50-Day Range: $1.88 to $1.88
• 52-Week Range: $0.83 to $2.12
• Volume: 597,714 shs
• Average Volume: 865,800 shs
• Market Capitalization: $245.45 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

EMC Stock Analysis - Frequently Asked Questions

How have EMC shares performed this year?

Emblem's stock was trading at $1.88 at the beginning of the year. Since then, EMC stock has increased by 0.0% and is now trading at $1.88.
View the best growth stocks for 2024 here.

How do I buy shares of Emblem?

Shares of EMC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Emblem own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Emblem investors own include Aurora Cannabis (ACB), Aphria (APHA), Organigram (OGI), Canopy Growth (WEED), ICC Labs (ICC), Lowe's Companies (LOW) and Emerald Health Therapeutics (EMH).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Cannabis
• Current Symbol: CVE:EMC
• CUSIP: N/A
• CIK: N/A
• Web: emblemcorp.com
• Phone: +1-647-2558106
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 20.89
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 30.01
• Current Ratio: 3.61
• Quick Ratio: 3.24

Sales & Book Value

• Annual Sales: $5.71 million
• Price / Sales: 43.02
• Cash Flow: $0.46 per share
• Price / Cash Flow: 4.08
• Book Value: $0.67 per share
• Price / Book: 2.82

Miscellaneous

• Outstanding Shares: 130,558,000
• Free Float: N/A
• Market Cap: $245.45 million
• Optionable: Not Optionable
• Beta: N/A